Coloplast delivered Q1 organic growth of 6% and EBIT growth 1 in constant currencies of 3%. Reported revenue in DKK grew 0%, reflecting 4%-points negative impact from currencies. Return on invested ...

In connection with the publication of Coloplast’s interim financial results for Q1 2025/26, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial ...

Reactivate now to get the information you were looking for! You will get digital access to reviews and ratings for over 8,500 products and services to help you make better choices for life’s big ...

Good morning to those of you here in the room, and also good morning to those of you joining us virtually today. On behalf of the Coloplast management team and on behalf of Investor Relations, I would ...

Urinary incontinence, or accidental bladder leakage, is common among men and women. It becomes more common with age, often due to medical issues or lifestyle changes. Many people manage urinary ...

Jul. 25—STEWARTVILLE, Minn. — Clearance by the Food and Drug Administration means a Stewartville manufacturer can now sell its fecal incontinence devices in the US, after years of being limited to the ...

Concerns raised over Altis sling as studies show higher rates of pain and complications compared to other mid-urethral slings No reasonable doctor would select this device if they were aware of what ...

The global stool management system market is on track for steady expansion, driven by increasing awareness of fecal incontinence management and continuous advancements in healthcare technology.

Overactive bladder (OAB) is a highly prevalent condition affecting millions of people worldwide. Effective treatment options exist, yet there is a great deal of interest in additional safe and ...

Projected to increase from USD 2.93 billion in 2023 to USD 4.55 billion by 2033, the incontinence skincare products market is anticipated to grow at a 4.5% CAGR during the forecast period. Within the ...